ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Jurnista 16 mg, Retardtabletten - 28 Tablette(n)
58351004 Janssen-Cilag AG
Jurnista 16 mg, Retardtabletten19.11.2008
  19.11.2008
Hydromorphone (N02AA03) 
WHO-DDD18.11.2023
01.01.30.28 Tablette(n)
01.01.30. 
A+  
Yes 
IPCI
103.41No
    
10 %135.10
7680583510047SynthetikaA
3983894 
Composition
hydromorphoni hydrochloridum 16 mg corresp. hydromorphonum 14.24 mg, macrogolum 200'000, povidonum K 29-32, magnesii stearas, E 321, macrogolum 2'000'000, natrii chloridum corresp. natrium 15.21 mg, hypromellosum, E 172 (nigrum), lactosum 0.026 mg, cellulosi acetas, macrogolum 3350, Überzug: lactosum monohydricum 6.79 mg, hypromellosum, E 171, E 172 (flavum), triacetinum, macrogolum 400, Drucktinte: E 172 (nigrum), hypromellosum, propylenglycolum, pro compresso obducto.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Hydromorphon Hydrochloride16 mg correspond Hydromorphone 14.24 mg
BAG: Active AgentDose
Hydromorphon Hydrochloride16 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
Cellulosi Acetas  
E 171 color.
E 172 Drucktinte
E 321  
Hypromellosum  
Lactosum0.026 mg 
Lactose Monohydrate6.79 mgÜberzug
Macrogol400  
Magnesii Stearas  
Sodium Chloride  
Povidonum K29-32 
Pro Compresso Obducto  
Propylenglycol  
Triacetinum  
 
Source
Data was imported : 04.02.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2022 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home